Machine learning explainability for survival outcome in head and neck squamous cell carcinoma
Rasheed Omobolaji Alabi1, Antti A Mäkitie2, Mohammed Elmusrati3
1Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Industrial Digitalization, School of Technology and Innovations, University of Vaasa, Vaasa, Finland.
Machine learning models accurately predict overall survival in head and neck squamous cell carcinoma (HNSCC) patients. Key factors include tumor characteristics, patient health, and lifestyle, enabling personalized treatment strategies.
Area of Science:
- Oncology
- Machine Learning in Medicine
- Cancer Prognostics
Background:
- Head and neck squamous cell carcinoma (HNSCC) diagnosis and treatment significantly impact patients psychologically and cause treatment toxicity.
- Evaluating patient outcomes is crucial for effective treatment planning and improved disease management in HNSCC.
Purpose of the Study:
- To develop a prognostic machine learning (ML) model integrating clinicopathological, treatment-related, and sociodemographic factors to predict overall survival (OS) in HNSCC patients.
- To explore the complementary prognostic potential of these diverse input parameters.
- To provide model explainability using Local Interpretable Model-agnostic Explanations (LIME) and SHapley Additive exPlanations (SHAP).
Main Methods:
- Recruited 419 HNSCC patients from three Swedish University Hospitals.
- Compared the performance of TabNet, extreme gradient boosting (XGBoost), and a voting ensemble for OS prediction.
- Utilized LIME and SHAP for model interpretability.
Main Results:
- TabNet and XGBoost achieved comparable prediction accuracies of 88.1%, with the voting ensemble reaching 88.7%.
- Key predictors for OS included p16 status, cancer stage, hemoglobin, age, T and N class, smoking history, BMI, treatment, erythrocyte count, and HPV status.
- Analysis revealed survival trends associated with p16, cancer stage, hemoglobin, age, HPV status, TNM staging, and socioeconomic factors.
Conclusions:
- Clinical implementation of ML models can facilitate individualized, risk-based therapeutic decision-making for HNSCC patients.
- Further validation using multi-institutional datasets and clinical trials is necessary for safe clinical implementation of these prognostic models.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Kaplan-Meier Approach
Assumptions of Survival Analysis
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
